Skip to content

Sign in Start free

Create your free account

Loading your page…

We care for the people who care.

No ads. No selling of your data. No third-party trackers.

Apps

Prognia
Ward
Suture
Osler

Library

Guidelines
Medicines
Articles
Calculators
Explore decks
Blog

Prognia

About
Pricing
Contact

Support us

Founders Wall

© 2026 Prognia · Amsterdam, the NetherlandsPrivacy TermsExchangeRate-API

Medicines · US (FDA)

FDA 2015

Prostaglandin analogues

Bimatoprost

Approved 5 May 2015EyeSolution/drops

The FDA lists this product in 20 strengths and forms.

Official labelAsk Osler about it

On this page

Composition
Strengths and forms
Official product information

The table holds no label text for this product yet, only the facts beside it. The official product information has the full text.

Composition

Active ingredients: BIMATOPROST 0.03%

Strengths and forms

The FDA lists each strength of a product separately; these pages share one label.

BIMATOPROST 0.03% · Solution/dropsThis page
BIMATOPROST 0.01% · SolutionANDA203056-001 · Tentative approval
BIMATOPROST 0.03% · Solution/dropsANDA090449-001 · Prescription
BIMATOPROST 0.01% · Solution/dropsANDA204638-001 · Tentative approval
BIMATOPROST 0.03% · Solution/dropsANDA207601-001 · Prescription
BIMATOPROST 0.03% · Solution/dropsANDA210515-001 · Prescription
BIMATOPROST 0.03% · Solution/dropsANDA202719-001 · Prescription
BIMATOPROST 0.01% · SolutionANDA203404-001 · Tentative approval
BIMATOPROST 0.03% · Solution/dropsANDA205537-001 · Prescription
BIMATOPROST 0.03% · Solution/dropsANDA201894-001 · Discontinued
BIMATOPROST 0.03% · Solution/dropsANDA203051-001 · Discontinued
BIMATOPROST 0.03% · Solution/drops

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

ANDA210126-001 · Prescription

BIMATOPROST 0.03 · SolutionANDA200487-001 · Tentative approval

BIMATOPROST 0.03% · Solution/dropsANDA202505-001 · Prescription

BIMATOPROST 0.03% · Solution/dropsANDA203299-001 · Discontinued

BIMATOPROST 0.03% · Solution/dropsANDA203991-001 · Discontinued

BIMATOPROST 0.01% · Solution/dropsANDA209797-001 · Tentative approval

BIMATOPROST 0.03% · Solution/dropsANDA210263-001 · Prescription

BIMATOPROST 0.01% · Solution/dropsANDA217289-001 · Prescription

BIMATOPROST 0.01% · Solution/dropsANDA218196-001 · Prescription

Official product information

Drugs@FDA lists the approved labels, letters and reviews for application ANDA202565.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Brand name: Bimatoprost
Drug class: Prostaglandin analogues
Route: Eye
Dosage form: Solution/drops
Applicant: Sandoz
Status: Prescription
FDA approval: 5 May 2015
Application: ANDA202565-001
RxCUI: 283810